COX20-related COX deficiency (mitochondrial complex IV deficiency nuclear type 11, MC4DN11) is a rare autosomal recessive nuclear form of isolated cytochrome c oxidase (COX, Complex IV) deficiency caused by biallelic variants in COX20 (FAM36A). COX20 is an inner-membrane assembly factor that acts as a chaperone for the mitochondrially encoded core catalytic subunit COX2, stabilizing newly synthesized COX2 and presenting it to the SCO1/SCO2 copper metallochaperone module during Complex IV biogenesis. Loss of COX20 destabilizes COX2 and causes assembly of the holoenzyme to stall, producing an isolated Complex IV deficiency. Unlike the fatal infantile cardioencephalomyopathy seen with some other nuclear COX defects, COX20-related disease characteristically presents as a comparatively slowly progressive neurological disorder dominated by early hypotonia, cerebellar ataxia, dysarthria, dystonia, and a sensory-predominant axonal neuropathy. It conforms to the conserved Complex IV assembly-deficiency mechanism, with the lesion localized to defective COX2 maturation.
Ask a research question about COX20-Related COX Deficiency. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: COX20-Related COX Deficiency
category: Mendelian
creation_date: "2026-06-15T00:00:00Z"
synonyms:
- COX20 deficiency
- FAM36A deficiency
- Mitochondrial complex IV deficiency, nuclear type 11
- MC4DN11
- COX20-related cytochrome c oxidase deficiency
description: >
COX20-related COX deficiency (mitochondrial complex IV deficiency nuclear
type 11, MC4DN11) is a rare autosomal recessive nuclear form of isolated
cytochrome c oxidase (COX, Complex IV) deficiency caused by biallelic variants
in COX20 (FAM36A). COX20 is an inner-membrane assembly factor that acts as a
chaperone for the mitochondrially encoded core catalytic subunit COX2,
stabilizing newly synthesized COX2 and presenting it to the SCO1/SCO2 copper
metallochaperone module during Complex IV biogenesis. Loss of COX20 destabilizes
COX2 and causes assembly of the holoenzyme to stall, producing an isolated
Complex IV deficiency. Unlike the fatal infantile cardioencephalomyopathy seen
with some other nuclear COX defects, COX20-related disease characteristically
presents as a comparatively slowly progressive neurological disorder dominated
by early hypotonia, cerebellar ataxia, dysarthria, dystonia, and a
sensory-predominant axonal neuropathy. It conforms to the conserved Complex IV
assembly-deficiency mechanism, with the lesion localized to defective COX2
maturation.
disease_term:
preferred_term: COX20-related COX deficiency (MC4DN11)
term:
id: MONDO:0033645
label: mitochondrial complex IV deficiency, nuclear type 11
parents:
- Mitochondrial Disease
- Inborn Error of Metabolism
pathophysiology:
- name: COX20 Loss and Defective COX2 Maturation
conforms_to: "complex_iv_assembly_deficiency#Complex IV Biogenesis Failure"
description: >
Biallelic COX20 variants cause loss of the inner-membrane COX2 chaperone.
COX20 binds newly synthesized COX2, stabilizes it, and presents it to the
SCO1/SCO2 copper-metallation module; in its absence COX2 is unstable and
Complex IV stalls at an early subassembly that contains COX1 (and COX4) but
is depleted of COX2, yielding isolated Complex IV biogenesis failure.
biological_processes:
- preferred_term: mitochondrial respiratory chain complex IV assembly
term:
id: GO:0033617
label: mitochondrial respiratory chain complex IV assembly
modifier: DECREASED
evidence:
- reference: PMID:23125284
reference_title: "A mutation in the FAM36A gene, the human ortholog of COX20, impairs cytochrome c oxidase assembly and is associated with ataxia and muscle hypotonia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Cells affected by the mutation accumulate subassemblies of complex IV that contain COX1 but are almost devoid of COX2 protein
explanation: Demonstrates that COX20 loss stalls Complex IV assembly at a COX2-deficient subassembly, i.e. failed Complex IV biogenesis.
- reference: PMID:24403053
reference_title: "Human COX20 cooperates with SCO1 and SCO2 to mature COX2 and promote the assembly of cytochrome c oxidase."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: These cell lines exhibit a severe, isolated CIV deficiency due to instability of COX2, a mitochondrion-encoded CIV subunit
explanation: COX20 knockout/knockdown human cell lines show isolated Complex IV deficiency caused by COX2 instability, establishing the molecular lesion.
- reference: PMID:24403053
reference_title: "Human COX20 cooperates with SCO1 and SCO2 to mature COX2 and promote the assembly of cytochrome c oxidase."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: We propose that COX20 acts as a chaperone in the early steps of COX2 maturation, stabilizing the newly synthesized protein and presenting COX2 to its metallochaperone module
explanation: Defines COX20's normal chaperone role in COX2 maturation, the function lost in MC4DN11.
downstream:
- target: Impaired Terminal Electron Transfer and ATP Synthesis
causal_link_type: DIRECT
description: Failure to mature and incorporate COX2 yields a catalytically deficient Complex IV.
- name: Impaired Terminal Electron Transfer and ATP Synthesis
conforms_to: "complex_iv_assembly_deficiency#Impaired Terminal Electron Transfer and ATP Synthesis"
description: >
Deficient Complex IV blocks electron transfer from cytochrome c to oxygen
and proton pumping, collapsing oxidative ATP synthesis and preferentially
injuring high-energy neural tissue (cerebellum, peripheral sensory axons,
skeletal muscle).
cell_types:
- preferred_term: neuron
term:
id: CL:0000540
label: neuron
biological_processes:
- preferred_term: mitochondrial electron transport, cytochrome c to oxygen
term:
id: GO:0006123
label: mitochondrial electron transport, cytochrome c to oxygen
modifier: DECREASED
- preferred_term: ATP synthesis coupled electron transport
term:
id: GO:0042775
label: mitochondrial ATP synthesis coupled electron transport
modifier: DECREASED
evidence:
- reference: PMID:23125284
reference_title: "A mutation in the FAM36A gene, the human ortholog of COX20, impairs cytochrome c oxidase assembly and is associated with ataxia and muscle hypotonia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: leads to a reduced activity and lower levels of complex IV and its protein subunits
explanation: Patient cells show reduced Complex IV activity, the biochemical basis for impaired terminal electron transfer and ATP synthesis.
downstream:
- target: Hypotonia
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: Bioenergetic failure in neural and skeletal-muscle tissue produces early hypotonia.
- target: Ataxia
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: Bioenergetic failure in the cerebellum produces progressive ataxia.
- target: Dysarthria
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: Cerebellar and extrapyramidal dysfunction downstream of Complex IV deficiency produces dysarthric speech.
- target: Dystonia
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: Energy failure in motor-control circuits contributes to dystonia in the COX20 movement-disorder phenotype.
- target: Areflexia
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: Sensory-predominant axonal neuropathy downstream of Complex IV deficiency produces areflexia.
- target: Sensory axonal neuropathy
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: Energy deficit in long sensory axons produces a sensory-predominant axonal neuropathy.
phenotypes:
- name: Hypotonia
description: Early/childhood hypotonia, often the presenting feature of COX20-related disease.
phenotype_term:
preferred_term: Hypotonia
term:
id: HP:0001252
label: Hypotonia
evidence:
- reference: PMID:23125284
reference_title: "A mutation in the FAM36A gene, the human ortholog of COX20, impairs cytochrome c oxidase assembly and is associated with ataxia and muscle hypotonia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: we describe a homozygous missense mutation in FAM36A from a patient who displays ataxia and muscle hypotonia
explanation: Muscle hypotonia is reported in the index COX20/FAM36A patient.
- name: Ataxia
description: Progressive cerebellar ataxia, a cardinal feature of COX20-related disease.
phenotype_term:
preferred_term: Cerebellar ataxia
term:
id: HP:0001251
label: Ataxia
clinical_course: PROGRESSIVE
evidence:
- reference: PMID:23125284
reference_title: "A mutation in the FAM36A gene, the human ortholog of COX20, impairs cytochrome c oxidase assembly and is associated with ataxia and muscle hypotonia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: we describe a homozygous missense mutation in FAM36A from a patient who displays ataxia and muscle hypotonia
explanation: Ataxia is reported in the index COX20/FAM36A patient.
- reference: PMID:30656193
reference_title: "Novel pathogenic COX20 variants causing dysarthria, ataxia, and sensory neuropathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: We report four subjects with features that include childhood hypotonia, areflexia, ataxia, dysarthria, dystonia, and sensory neuropathy
explanation: Confirms ataxia across four additional COX20 subjects.
- name: Dysarthria
description: Dysarthric speech, part of the COX20-related cerebellar/extrapyramidal syndrome.
phenotype_term:
preferred_term: Dysarthria
term:
id: HP:0001260
label: Dysarthria
evidence:
- reference: PMID:30656193
reference_title: "Novel pathogenic COX20 variants causing dysarthria, ataxia, and sensory neuropathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: We report four subjects with features that include childhood hypotonia, areflexia, ataxia, dysarthria, dystonia, and sensory neuropathy
explanation: Dysarthria is reported across four COX20 subjects.
- name: Dystonia
description: Dystonia, reported as part of the COX20-related movement disorder.
phenotype_term:
preferred_term: Dystonia
term:
id: HP:0001332
label: Dystonia
evidence:
- reference: PMID:30656193
reference_title: "Novel pathogenic COX20 variants causing dysarthria, ataxia, and sensory neuropathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: We report four subjects with features that include childhood hypotonia, areflexia, ataxia, dysarthria, dystonia, and sensory neuropathy
explanation: Dystonia is reported across four COX20 subjects.
- name: Areflexia
description: Areflexia, reflecting the associated sensory-predominant peripheral neuropathy.
phenotype_term:
preferred_term: Areflexia
term:
id: HP:0001284
label: Areflexia
evidence:
- reference: PMID:30656193
reference_title: "Novel pathogenic COX20 variants causing dysarthria, ataxia, and sensory neuropathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: We report four subjects with features that include childhood hypotonia, areflexia, ataxia, dysarthria, dystonia, and sensory neuropathy
explanation: Areflexia is reported across four COX20 subjects.
- name: Sensory axonal neuropathy
description: >
Sensory-predominant axonal neuropathy, a recurrent feature of COX20-related
disease and the dominant presentation in some families.
phenotype_term:
preferred_term: Sensory axonal neuropathy
term:
id: HP:0003390
label: Sensory axonal neuropathy
evidence:
- reference: PMID:30656193
reference_title: "Novel pathogenic COX20 variants causing dysarthria, ataxia, and sensory neuropathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: We report four subjects with features that include childhood hypotonia, areflexia, ataxia, dysarthria, dystonia, and sensory neuropathy
explanation: Sensory neuropathy is reported across four COX20 subjects.
- reference: PMID:31079202
reference_title: "Observation of novel COX20 mutations related to autosomal recessive axonal neuropathy and static encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: we describe two patients from a non-consanguineous family exhibiting autosomal recessive sensory-dominant axonal neuropathy and static encephalopathy
explanation: A second family presents with sensory-dominant axonal neuropathy, confirming peripheral nerve involvement.
genetic:
- name: COX20 pathogenic variants causing MC4DN11
gene_term:
preferred_term: COX20
term:
id: hgnc:26970
label: COX20
inheritance:
- name: Autosomal recessive
evidence:
- reference: PMID:31079202
reference_title: "Observation of novel COX20 mutations related to autosomal recessive axonal neuropathy and static encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: we describe two patients from a non-consanguineous family exhibiting autosomal recessive sensory-dominant axonal neuropathy and static encephalopathy
explanation: Compound heterozygous COX20 variants segregating recessively in a non-consanguineous family establish autosomal recessive inheritance.
features: >
Biallelic COX20 variants — homozygous (e.g., p.Thr52Pro) in consanguineous
families and compound heterozygous (e.g., p.Lys14Arg with p.Trp74Cys, or a
c.157+3G>C splice variant) in non-consanguineous families — impair COX2
maturation and cause MC4DN11.
evidence:
- reference: PMID:31079202
reference_title: "Observation of novel COX20 mutations related to autosomal recessive axonal neuropathy and static encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: A homozygous mutation (p.Thr52Pro) in COX20 gene has been previously described to cause muscle hypotonia and ataxia
explanation: Summarizes the founding homozygous COX20 variant and its core phenotype, establishing COX20 as the causal gene.
treatments:
- name: Supportive and Metabolic Care
description: >
No curative therapy exists; management is supportive, addressing the
movement disorder (ataxia, dystonia, dysarthria), peripheral neuropathy, and
any metabolic decompensation, with physiotherapy and rehabilitation.
treatment_term:
preferred_term: supportive care
term:
id: MAXO:0000950
label: supportive care